Sheets Smith Wealth Management Moderna, Inc. Transaction History

Sheets Smith Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 26, 2023	BUY	$135.66 - $197.02 $179,749 - $261,051	1,325 Added 860.39%	1,479 $227,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $179,749 - $261,051	-1,325 Reduced 89.59%	154 $23,000
Q4 2022 Mar 08, 2023	BUY	$118.38 - $210.04 $175,084 - $310,649	1,479 New	1,479 $265,000
Q1 2022 May 02, 2022	SELL	$126.46 - $235.05 $290,858 - $540,615	-2,300 Reduced 60.86%	1,479 $255,000
Q4 2021 Jan 20, 2022	SELL	$225.82 - $368.51 $4,742 - $7,738	-21 Reduced 0.55%	3,779 $960,000
Q1 2021 Apr 23, 2021	BUY	$109.18 - $185.98 $120,098 - $204,578	1,100 Added 40.74%	3,800 $498,000
Q4 2020 Jan 13, 2021	BUY	$65.74 - $169.86 $177,498 - $458,622	2,700 New	2,700 $282,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Sheets Smith Wealth Management with notifications on news.